These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 15299208)
1. Development and clinical application in arthritis of a new immunoassay for serum type IIA procollagen NH2 propeptide. Rousseau JC; Sandell LJ; Delmas PD; Garnero P Methods Mol Med; 2004; 101():25-37. PubMed ID: 15299208 [TBL] [Abstract][Full Text] [Related]
2. Serum levels of type IIA procollagen amino terminal propeptide (PIIANP) are decreased in patients with knee osteoarthritis and rheumatoid arthritis. Rousseau JC; Zhu Y; Miossec P; Vignon E; Sandell LJ; Garnero P; Delmas PD Osteoarthritis Cartilage; 2004 Jun; 12(6):440-7. PubMed ID: 15135140 [TBL] [Abstract][Full Text] [Related]
3. Type IIA procollagen: expression in developing chicken limb cartilage and human osteoarthritic articular cartilage. Nah HD; Swoboda B; Birk DE; Kirsch T Dev Dyn; 2001 Apr; 220(4):307-22. PubMed ID: 11307165 [TBL] [Abstract][Full Text] [Related]
4. Type IIA procollagen in development of the human intervertebral disc: regulated expression of the NH(2)-propeptide by enzymic processing reveals a unique developmental pathway. Zhu Y; McAlinden A; Sandell LJ Dev Dyn; 2001 Apr; 220(4):350-62. PubMed ID: 11307168 [TBL] [Abstract][Full Text] [Related]
5. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis. Charni N; Juillet F; Garnero P Arthritis Rheum; 2005 Apr; 52(4):1081-90. PubMed ID: 15818703 [TBL] [Abstract][Full Text] [Related]
6. A Novel High Sensitivity Type II Collagen Blood-Based Biomarker, PRO-C2, for Assessment of Cartilage Formation. Luo Y; He Y; Reker D; Gudmann NS; Henriksen K; Simonsen O; Ladel C; Michaelis M; Mobasheri A; Karsdal M; Bay-Jensen AC Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30404167 [TBL] [Abstract][Full Text] [Related]
7. A unique tool to selectively detect the chondrogenic IIB form of human type II procollagen protein. Aubert-Foucher E; Mayer N; Pasdeloup M; Pagnon A; Hartmann D; Mallein-Gerin F Matrix Biol; 2014 Feb; 34():80-8. PubMed ID: 24055103 [TBL] [Abstract][Full Text] [Related]
8. Procollagen II C-propeptide in joint fluid: changes in concentration with age, time after knee injury, and osteoarthritis. Lohmander LS; Yoshihara Y; Roos H; Kobayashi T; Yamada H; Shinmei M J Rheumatol; 1996 Oct; 23(10):1765-9. PubMed ID: 8895155 [TBL] [Abstract][Full Text] [Related]
9. Type IIA procollagen amino propeptide is localized in human embryonic tissues. Oganesian A; Zhu Y; Sandell LJ J Histochem Cytochem; 1997 Nov; 45(11):1469-80. PubMed ID: 9358849 [TBL] [Abstract][Full Text] [Related]
10. Alternative splice form of type II procollagen mRNA (IIA) is predominant in skeletal precursors and non-cartilaginous tissues during early mouse development. Sandell LJ; Nalin AM; Reife RA Dev Dyn; 1994 Feb; 199(2):129-40. PubMed ID: 8204907 [TBL] [Abstract][Full Text] [Related]
11. [Clinical usefulness of the measurement of type-II procollagen carboxypeptide (C-II propeptide, pColl-II-C) in synovial fluid as a marker of collagen metabolism in cartilage]. Shinmei M; Nagaya I; Miyanaga Y; Iwata H; Yamamoto S; Torisu T; Fujii K; Fukubayashi T; Kondo M; Kurosaka M Ryumachi; 1992 Oct; 32(5):453-60. PubMed ID: 1440081 [TBL] [Abstract][Full Text] [Related]
12. Heritability assessment of cartilage metabolism. A twin study on circulating procollagen IIA N-terminal propeptide (PIIANP). Munk HL; Svendsen AJ; Hjelmborg Jv; Sorensen GL; Kyvik KO; Junker P Osteoarthritis Cartilage; 2014 Aug; 22(8):1142-7. PubMed ID: 25008205 [TBL] [Abstract][Full Text] [Related]
13. Circadian pattern and the effect of standardized physical exercise on procollagen IIA N-peptide (PIIANP) in rheumatoid arthritis at different stages and in healthy individuals. Christensen AF; Lottenburger T; Lindegaard HM; Junker K; Hørslev-Petersen K; Junker P Biomarkers; 2010 Feb; 15(1):80-5. PubMed ID: 19814628 [TBL] [Abstract][Full Text] [Related]
14. Effects of etanercept on serum biochemical markers of cartilage metabolism in patients with spondyloarthropathy. Briot K; Roux C; Gossec L; Charni N; Kolta S; Dougados M; Garnero P J Rheumatol; 2008 Feb; 35(2):310-4. PubMed ID: 18203315 [TBL] [Abstract][Full Text] [Related]
15. Type IIA procollagen containing the cysteine-rich amino propeptide is deposited in the extracellular matrix of prechondrogenic tissue and binds to TGF-beta1 and BMP-2. Zhu Y; Oganesian A; Keene DR; Sandell LJ J Cell Biol; 1999 Mar; 144(5):1069-80. PubMed ID: 10085302 [TBL] [Abstract][Full Text] [Related]
16. Preferential expression of alternatively spliced mRNAs encoding type II procollagen with a cysteine-rich amino-propeptide in differentiating cartilage and nonchondrogenic tissues during early mouse development. Ng LJ; Tam PP; Cheah KS Dev Biol; 1993 Oct; 159(2):403-17. PubMed ID: 8405667 [TBL] [Abstract][Full Text] [Related]
17. Evidence for altered synthesis of type II collagen in patients with osteoarthritis. Nelson F; Dahlberg L; Laverty S; Reiner A; Pidoux I; Ionescu M; Fraser GL; Brooks E; Tanzer M; Rosenberg LC; Dieppe P; Robin Poole A J Clin Invest; 1998 Dec; 102(12):2115-25. PubMed ID: 9854047 [TBL] [Abstract][Full Text] [Related]
18. Differential association of the N-propeptide of collagen IIA (PIIANP) and collagen II C-telopeptide (CTX-II) with synovitis and erosions in early and longstanding rheumatoid arthritis. Christensen AF; Lottenburger T; Lindegaard H; Christgau S; Hørslev-Petersen K; Junker P Clin Exp Rheumatol; 2009; 27(2):307-14. PubMed ID: 19473573 [TBL] [Abstract][Full Text] [Related]
19. A 5-yr longitudinal study of type IIA collagen synthesis and total type II collagen degradation in patients with knee osteoarthritis--association with disease progression. Sharif M; Kirwan J; Charni N; Sandell LJ; Whittles C; Garnero P Rheumatology (Oxford); 2007 Jun; 46(6):938-43. PubMed ID: 17387119 [TBL] [Abstract][Full Text] [Related]